Embed Size (px)
Citation preview
Capabilities Statement P&MA Support Services
Parioforma Ltd 55 Princes Gate Exhibition Road
South Kensington London SW7 2PN
United Kingdom www.parioforma.com
© Parioforma Ltd 2016 2
About Parioforma
• Founded in 2000, Parioforma is an international business consultancy.
• At Parioforma we believe that a successful P&MA Strategy begins with reliable intelligence.
• We are focused on delivering ad hoc actionable global and local P&MA intelligence in the fields of pharmaceutical, biotechnology, IVD and medical devices.
Key benefits of working with Parioforma
Bespoke studies – tailored needs and timelines.
Affordable pricing – making budgets go further.
High quality research – experienced team with 10-25+ years experience in Pharma/ Healthcare industries.
Strategic pointers - helps clients better understand the research and the implications for their study.
© Parioforma Ltd 2016 3
• We cover traditional (North America & Western Europe) as well as emerging & complicated markets.
• We have experienced people in each of the markets we cover – NB new markets can be added with sufficient notice.
Complicated Markets
© Parioforma Ltd 2016 4
Experience & local
knowledge
Local experts & partners
In-country native
language speakers
Parioforma Expertise
Our Network
• In addition to our core team, Parioforma has built up a global network of in-country partners and experts:
Parioforma has access to a network of associate native language speakers.
We have experience in these markets – in many we have worked across multiple therapeutic categories so we have built a ‘tried & tested’ contact network.
The advantage of using local independent partners enables Parioforma to leverage deep knowledge and insights into national market situations.
© Parioforma Ltd 2016 5
• We specialize in delivering ad hoc actionable global and local P&MA intelligence support services:
P&MA Support Services
Secondary Research
Local language internet searches
Data validation
Landscape profiling
Primary Research
Consultancy
Depth qualitative interviews (in-person,
telephone, internet-assisted)
Advisory boards, payer panels, focus groups
Analytical support – interpretation of results
Joint preparation of slides
© Parioforma Ltd 2016 6
• Primary research is a specific core competence:
– Depth qualitative interviews (in-person, telephone, Skype, document-sharing)
– Advisory boards, payer panels and focus groups
Primary Research
Recruitment
Identification and recruitment of key respondents:
Payers, proxy-payers, payer advisors
KOLs, consultants, healthcare specialists, in-country experts, nurses
Pharmacists
Translation
Translation of discussion guides and interview support materials:
Tried and tested group of translators
Moderation
Interviews in English or native language:
We are able to field native language speakers/ simultaneous interpreters from our associate network
Transcription
Transcripts - verbatim or pre-analysed to client templates:
Transcripts provided on a ‘rolling basis’ as they are completed
© Parioforma Ltd 2016 7
• Pharma markets in emerging markets have been continuously witnessing robust growth on account of:
– Increasing prevalence of diseases
– Rising healthcare spending
– Increasing affordability
• Political and economic transition since the 1990s has resulted in many changes in the health sectors of these countries.
• Many have adopted social health insurance (SHI) models in attempts to move away from centrally planned and state controlled healthcare financing and coverage.
• Healthcare reforms have been accompanied by a need for increased spending driven by:
– Economic growth
– Ageing populations
– Advances in medical technology
– Expanding expectations on the part of national populations
• Reforms and increased spending have
brought new challenges highlighting the need for:
– Cost containment
– Improvements in quality of services
– Improvements in equity of access
– Assurance of rational and transparent spending decisions
• Until recently, many countries have implemented new technologies with little or no regard for costs or effectiveness but increased attention is now being paid to the implementation of measures to manage costs and obtain better value for money:
– Reimbursement and pricing controls – e.g. reference pricing systems
– Establishment of positive lists
– Cost sharing – e.g. co-payments
– Adoption of the use of HTA in healthcare decision making – e.g. listing status, reimbursement level, pricing, practice guidelines
– Emerging HTA guidelines
Emerging Market Insights
© Parioforma Ltd 2016 8
London Office
Charles Rowlands Senior Partner
Join me on 55 Prince’s Gate Exhibition Road London SW7 2PN United Kingdom
Tel: +44 (0) 7803 907577 www.parioforma.com
Associate Offices
USA Intrix Corp, Darien Connecticut
Eastern Europe IMRP, Moscow
Brazil Intrix Corp, São Paulo
Japan TRN, Tokyo
Please don't hesitate to contact us for an informal discussion – either by telephone or by email at:
Project proposals are provided entirely free and without obligation.
Contact
